Ignite Creation Date:
2024-05-05 @ 10:35 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01141153
Status:
UNKNOWN
Last Update Posted:
2015-02-24
First Post:
2010-06-09
Brief Title:
Anticoagulation in Stent Intervention
Sponsor:
Hospital Universitari Vall dHebron Research Institute
Organization:
Hospital Universitari Vall dHebron Research Institute
Study Overview
Official Title:
Test of Efficacy and Safety of the Dual Antiplatelet Therapy Compared to the Combination of Oral Anticoagulant Therapy Dual Antiplatelet Therapy in Patients With Atrial Fibrillation With Low-moderate Risk Submitted to Coronary Stent Implantation
Status:
UNKNOWN
Status Verified Date:
2015-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MUSICA-2
Brief Summary:
Objective
The main objective is to evaluate the pattern of dual antiplatelet therapy aspirin 300 mg day clopidogrel 75 mg day compared to the use of the triple regimen Acenocoumarol as control acetylsalicylic acid 100 mg day Clopidogrel 75 mg day in patients with atrial fibrillation low-moderate risk of stroke CHADS 2 who are undergoing PCI-S
Design
Randomized parallel with two arms blind evaluation by third parties
Patients
304 patients undergoing PCI-S with atrial fibrillation low-moderate risk of stroke CHADS 2 which requires prevention of thrombosis
The main objective is to evaluate the pattern of dual antiplatelet therapy aspirin 300 mg day clopidogrel 75 mg day compared to the use of the triple regimen Acenocoumarol as control acetylsalicylic acid 100 mg day Clopidogrel 75 mg day in patients with atrial fibrillation low-moderate risk of stroke CHADS 2 who are undergoing PCI-S
Design
Randomized parallel with two arms blind evaluation by third parties
Patients
304 patients undergoing PCI-S with atrial fibrillation low-moderate risk of stroke CHADS 2 which requires prevention of thrombosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2009-017256-27 | EUDRACT_NUMBER | None | None |